Zhengye Biotechnology Holding (ZYBT) Current Assets (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Current Assets of $19.4 million for Q4 2025, down 21.62% year-over-year from $24.7 million in Q4 2024, and down 31.1% quarter-over-quarter from $28.1 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Current Assets (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Current Assets for 3 consecutive years, with $19.4 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Current Assets fell 21.62% year-over-year to $19.4 million; the TTM figure through Dec 2025 stood at $19.4 million (down 21.62% YoY), while the FY2025 annual figure was $19.6 million, down 19.23% from the prior year.
- Current Assets declined to $19.4 million in Q4 2025 per ZYBT's latest filing, from $28.1 million in the prior quarter.
- Across five years, Current Assets topped out at $28.1 million in Q2 2025 and bottomed at $19.4 million in Q4 2025.
- Historically, Current Assets has averaged $24.6 million across 3 years, with a median of $25.5 million in 2024.
- Annual changes were most pronounced in 2024 — Current Assets fell 5.95% — and 2025, when it slipped 21.62%.
- Zhengye Biotechnology Holding's Current Assets stood at $26.3 million in 2023, then retreated by 5.95% to $24.7 million in 2024, then decreased by 21.62% to $19.4 million in 2025.
- Business Quant data shows ZYBT's Current Assets at $19.4 million in Q4 2025, $28.1 million in Q2 2025, and $24.7 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Zhengye Biotechnology Holding | 88.07 Mn | 80.75 Mn | - | 19.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 19.38 Mn |
| Jun 30, 2025 | 28.12 Mn |
| Dec 31, 2024 | 24.72 Mn |
| Dec 31, 2023 | 26.28 Mn |